Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...

Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...

AskBio Inc., an RTP-based gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has received U.S. Food and Drug Administration (FDA) acceptance of its ...

Nine-year follow-up of gene therapy in haemophilia B confirms long-term safety and reduced bleeding, though full capsid ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Scientists in the United Kingdom say they’ve found “strong circumstantial evidence” linking an obscure type of sidekick virus called adeno-associated virus to unexplained cases of liver damage in ...

This article shows how a combination of nanoparticle tracking analysis (NTA) technique and a gold labeling method can be used to rapidly measure the concentration and size of Adeno-Associated Virus ...

An outbreak of acute severe, unexplained hepatitis in previously healthy children in 2022 may be linked to adeno-associated virus 2, or AAV2, according to three independent studies published Thursday ...